Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinecatechins for Secondary Provoked Vestibulodynia in Postmenopausal Women
NCT03682601Phase 2Terminated
- Sponsor
- GTO Pharmaceutical
- Start
- Aug 2018
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of sinecatechins in vestibulodynia, dyspareunia, sponsored by GTO Pharmaceutical. Started Aug 2018; status: terminated.
02
Drugs
sinecatechins
03
Conditions
vestibulodyniadyspareunia
Beyond the preview
Go deeper on NCT03682601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682601.